Pfizer Investment: Signs Strategic Partnership With China Resources Pharmaceutical Commercial Group to Jointly Commercialize Four Key Drugs for Breast and Lung Cancer
輝瑞投資:與中國醫藥集團商業公司簽署戰略合作協議,共同商業化四種關鍵藥品用於乳腺癌和肺癌
Pfizer Investment: Signs Strategic Partnership With China Resources Pharmaceutical Commercial Group to Jointly Commercialize Four Key Drugs for Breast and Lung Cancer
輝瑞投資:與中國醫藥集團商業公司簽署戰略合作協議,共同商業化四種關鍵藥品用於乳腺癌和肺癌
譯文內容由第三人軟體翻譯。